FAF Jumps As First American Financial Tops Q2 And Wins Bullish Targets

First American Corporation (New) stocks have been trading up by 8.95 percent amid strong earnings-driven optimism boosting investor sentiment.

Weekly Update Jul 20 – Jul 24, 2026: On Sunday, July 26, 2026 First American Corporation (New) stock [NYSE: FAF] is trending up by 8.95%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Finance industry expert:

Analyst sentiment – positive

First American Financial sits in a solid competitive position in title and real estate data, with 8.7% net margin and low leverage (total debt-to-equity 0.04, leverage ratio 3.3). Revenue of $7.45B is growing modestly but steadily (three‑year CAGR 3.2%), and ROE of 12.8% is above most P&C and title peers, supported by strong investment income. The stock trades at 10.8x earnings and 0.93x sales with a 2.9% dividend yield, an attractive valuation versus insurance sector averages.

Technically, FAF’s weekly tape shows a brief pullback from 71.85 to 68.96 followed by an aggressive reversal to 75.13, indicating strong dip buying and a continuation of the prevailing uptrend. Intraday 5‑minute action (not provided in detail) aligns with a momentum push through prior highs on higher volume into the $75 area. The key actionable level is support at $70: above it, long entries are favored with stops just below $69 and upside targeting mid‑$80s.

Fundamentally and sentiment-wise, FAF is outperforming Finance and Insurance benchmarks, with Q2 revenue and EPS beats and a 14% adjusted pretax title margin despite weak residential volumes. Multiple Buy initiations and target hikes to $85–$99 confirm institutional sponsorship. The Esri ArcGIS data integration adds a scalable fee‑based growth leg and multiple expansion potential. I see fair value in the $85–$90 range over 12 months, with near‑term support at $70 and resistance at $80–$82.

Quick Financial Overview

First American Financial (FAF) just posted a clean beat in Q2. Adjusted EPS came in at $2.08, up from $1.53 a year ago and ahead of consensus around $1.82–$1.84, while revenue rose to about $2.1–$2.12B versus $2.03B expected. This lines up with a solid pretax profit margin near 8.5% and total profit margin around 8.7%, confirming that the core engine is running efficiently even with a soft residential backdrop.

On the balance sheet, First American Financial shows low leverage, with total debt to equity at just 0.04 and common equity above $5.6B. Returns are respectable for a cyclical name, with return on equity near 9.3% historically and about 12.8% on a last-twelve-month basis. Annual revenue is around $7.45B, with modest multi‑year growth, and traders also get a cash dividend yield around 2.9% on a roughly $2.2 per‑share payout.

Price action backs the bullish narrative. Weekly candles show FAF pulling back from $71.85 down to $68.96 before ripping to $75.13, signaling a strong momentum surge after earnings and analyst upgrades. Intraday, the 5‑minute data show a drive from about $70.96 up to nearly $75.96, closing at $75.13, which is a powerful expansion day that often attracts breakout traders watching for continuation above recent highs.

Conclusion

First American Financial Trading Set-Up And Outlook

The current backdrop around FAF is a classic momentum‑plus‑fundamentals story. Earnings are trending higher, with Q2 adjusted EPS at $2.08 and revenue at roughly $2.12B, both ahead of expectations and up year over year. That strength is being recognized by the Street, with Benchmark launching coverage at $85, Keefe Bruyette Woods moving to $86, and Deutsche Bank pushing a more aggressive $99 target while keeping Buy ratings in place.

Beyond the title cycle, First American Financial is leaning into data. The integration of its nationwide, normalized property datasets into Esri’s ArcGIS ecosystem shows a push toward higher‑margin, recurring data and analytics revenue, which can smooth out the swings from residential volume. At the same time, the chart is confirming the story: a sharp weekly reversal off $68.96 to $75.13 and a strong intraday push toward the mid‑$70s suggest active buyers are in control.

For traders, the key is to treat FAF as a cyclical, earnings‑sensitive name with growing data optionality, not a sleepy income stock. That also means applying strict trading discipline and respecting price action. As millionaire penny stock trader and teacher Tim Sykes says, “Be patient, don’t force trades, and let the perfect setups come to you.”. Pullbacks toward prior breakout zones could matter for entries, while any failure back through recent lows would flag that the post‑earnings momentum is fading. As I tell my students, “You do not chase the story; you trade the levels that prove the story is real.”

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

• Penny Stocks Trading Guide
• Best Penny Stocks Under $1 to Buy Today
• Top 8 Penny Stocks to Watch on Robinhood

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

• AI Penny Stocks
• Robinhood Penny Stocks
• Top Biotech Stocks